title: Patient satisfaction following Bio-Alcamid injection for facial contour defects.
abstract: Bio-Alcamid, a polyalkylimide gel, can be injected into subcutaneous tissue as an endoprosthesis for correcting contour deformities and soft tissue defects. We have reviewed its facial uses and longer-term outcomes over a 7-year period, including a patient satisfaction survey. 69 patients were included in the study, 89.9% undergoing treatment secondary to HIV-associated facial lipoatrophy. 55.0% of patients responded to questionnaires: 52.5% experienced severe pain associated with injections, and 50.0% experienced at least one complication (migration, hardening, irregularity). 94.4% stated an improvement in their cheek volume, 77.8% would undergo the procedure again, and 86.1% would recommend the treatment to a friend. Despite the relatively high patient satisfaction, we no longer recommend this treatment to our patients for cosmetic indications, due to significant long-term complication rates.
authors: Department of Plastic and Reconstructive Surgery, Queen Elizabeth Hospital Birmingham, University Hospital Birmingham NHS Trust, Edgbaston, Birmingham, UK. davidgeorge@doctors.org.uk
authors: D A
authors: DA
authors: George
authors: E
authors: E
authors: Erel
authors: R
authors: R
authors: Waters
mesh_terms: D000180:Acrylic Resins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001672:Biocompatible Materials / Q000009:adverse effects / Q000627:therapeutic use*; D003357:Cosmetic Techniques / Q000009:adverse effects; D005145:Face; D005260:Female; D039682:HIV-Associated Lipodystrophy Syndrome / Q000628:therapy*; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D017060:Patient Satisfaction; D012189:Retrospective Studies; D011795:Surveys and Questionnaires; D016896:Treatment Outcome
chemical_list: D000180:Acrylic Resins; C470344:Bio-Alcamid; D001672:Biocompatible Materials